Integra LifeSciences Holdings Corporation (IART) Stock

NASDAQ: IARTProvides surgical implants and medical instruments for orthopedic, neurosurgical, and general surgical procedures, aiming to enhance surgical outcomes and patient care.

Integra LifeSciences stock price chart

IART stock quote & key statistics

Integra LifeSciences earnings per share

Income →
Earnings per share

Integra LifeSciences revenue & net income

Income →
RevenueNet income

Integra LifeSciences annual financials

Income statement →
Integra LifeSciences Holdings Corporation revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$1.64B-$516.5M$2.23
FY2024$1.61B-$6.9M$2.56
FY2023$1.54B$67.7M$3.10
FY2022$1.56B$180.6M$3.36
FY2021$1.54B$169.1M$3.18

Fiscal year ending December 31. Source: company filings via EODHD.

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation, headquartered in Princeton, New Jersey, is a leading developer, manufacturer, and marketer of surgical implants and medical instruments used across diverse medical specialties. Established in 1989, the company operates through two main segments: Codman Specialty Surgical and Tissue Technologies. Its comprehensive product portfolio includes advanced solutions for neurosurgery, extremity reconstruction, and general surgery.

Within its Codman Specialty Surgical segment, Integra offers a range of neurosurgery and neuro critical care products. These include innovative equipment for tissue ablation, dural repair, cerebral spinal fluid management, intracranial monitoring, and cranial stabilization. The company also provides surgical headlamps, instrumentation, asset management software, and after-market services to enhance surgical precision and efficiency.

Under the Tissue Technologies segment, Integra LifeSciences focuses on regenerative technology products for wound treatment, as well as surgical tissue repair solutions for hernia repair, peripheral nerve protection, and tendon repair. Its extensive offerings encompass skin and wound repair, plastics and surgical reconstruction, bone grafts, and specialized products for nerve and tendon repair. Serving a global customer base, including hospitals, surgery centers, and healthcare providers worldwide, Integra continues to innovate and expand its impact in advancing surgical outcomes and patient care.

Integra LifeSciences stock FAQ

What is the Integra LifeSciences stock ticker symbol?

Integra LifeSciences Holdings Corporation trades on the NASDAQ under the ticker symbol IART.

What sector and industry is Integra LifeSciences in?

Integra LifeSciences Holdings Corporation is classified in the Healthcare sector, Medical Devices industry.

How many employees does Integra LifeSciences have?

Integra LifeSciences Holdings Corporation has about 4,427 full-time employees.

What were Integra LifeSciences's revenue and earnings last fiscal year?

Integra LifeSciences reported revenue of $1.64B and net income of -$516.5M in fiscal 2025, with earnings per share of $2.23. Revenue grew 1.5% from the prior year.

Is Integra LifeSciences in the S&P SmallCap 600?

Yes. Integra LifeSciences Holdings Corporation (IART) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.

Is Integra LifeSciences in the Russell 2000?

Yes. Integra LifeSciences Holdings Corporation (IART) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Integra LifeSciences go public?

Integra LifeSciences stock began trading on August 16, 1995.

S&P SmallCap 600 Medical Devices stocks

All S&P SmallCap 600 →